Clinical Study
Maternal Characteristics Influencing the Development of Gestational Diabetes in Obese Women Receiving 17-alpha-Hydroxyprogesterone Caproate
Table 2
Logistic regression results for adjusted risk of developing GDM.
| | | P value | OR (95% CI) |
| | 17OHPC initiation at 16–20 weeks | 0.025 | 1.67 (1.07, 2.63) | | 17OHPC initiation at 21–24 weeks | 0.515 | 1.22 (0.66, 2.26) | | AMA (maternal age ≥ 35 years) | 0.001 | 2.11 (1.37, 3.25) | | Morbid obesity > 39.9 kg/m2 | 0.063 | 1.60 (0.97, 2.63) |
|
|
